Cyclophosphamide for lupus during pregnancy.

Abstract:

:Severe systemic lupus erythematosus often requires the use of cyclophosphamide in women of reproductive age. As cyclophosphamide is generally avoided during pregnancy because of its teratogenic risk, its impact on fetal survival is poorly understood. This is a case series of lupus patients exposed to cyclophosphamide during pregnancy. We reviewed pregnancies in patients with lupus seen at a large university hospital between October 1986 and September 2003. The pregnancies were evaluated prospectively for cyclophosphamide exposure, lupus activity, and fetal outcome. Comparison was made between pregnancies with severe lupus requiring cyclophosphamide and those that did not. We identified four pregnancies with cyclophosphamide exposure. Two pregnancies were inadvertently exposed to cyclophosphamide early in the first trimester; both resulted in first trimester miscarriages. Two patients were administered cyclophosphamide for severe lupus nephritis and thrombocytopenia during the second trimester. Soon after the administration of cyclophosphamide, both pregnancies ended with fetal demise. Pregnancies exposed to cyclophosphamide for severe lupus flare resulted in a higher rate of fetal losses than pregnancies with severe lupus but not requiring the drug (100% versus 31.25%). In conclusion we present four pregnancies exposed to cyclphosphamide, each ending with pregnancy loss. Based on our experience, the survival of the fetus is strongly in doubt when cyclophosphamide is required to treat lupus in the mother.

journal_name

Lupus

journal_title

Lupus

authors

Clowse ME,Magder L,Petri M

doi

10.1191/0961203305lu2169oa

subject

Has Abstract

pub_date

2005-01-01 00:00:00

pages

593-7

issue

8

eissn

0961-2033

issn

1477-0962

journal_volume

14

pub_type

杂志文章

相关文献

LUPUS文献大全
  • Associations of four common VDR polymorphisms with rheumatoid arthritis and systemic lupus erythematosus: evidence from a meta-analysis.

    abstract::Associations of polymorphisms in vitamin D receptor (VDR) with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) have already been explored by many studies. The aim of this meta-analysis was to better clarify associations between polymorphisms in VDR and RA/SLE by combing the results of all relevant stu...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203320909432

    authors: Zhang WT,Jin TF,Chen L

    更新日期:2020-04-01 00:00:00

  • Ethnic differences in the epidemiology of cutaneous lupus erythematosus in New Zealand.

    abstract::Background The prevalence and variation by ethnicity of cutaneous lupus in New Zealand is not known. Therefore, a cross-sectional study to determine the prevalence and variation by ethnicity of cutaneous lupus in the ethnically diverse community of South Auckland, New Zealand, was undertaken. Methods Multiple sources ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203316651745

    authors: Jarrett P,Thornley S,Scragg R

    更新日期:2016-11-01 00:00:00

  • Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.

    abstract:INTRODUCTION:The use of hydroxychloroquine (HCQ) in patients with systemic lupus erythematosus (SLE) offers a wide range of benefits. However, there are evidence in favour of cardiotoxicity, including heart conduction disturbances and congestive heart failure. OBJECTIVE:To determine the effects of HCQ in the resting h...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315580870

    authors: Cairoli E,Danese N,Teliz M,Bruzzone MJ,Ferreira J,Rebella M,Cayota A

    更新日期:2015-10-01 00:00:00

  • Antimalarial-induced cardiomyopathy: a systematic review of the literature.

    abstract::Background Antimalarials (AMs) are widely used in the treatment of connective tissue diseases. Their main side effect is retinal damage, while heart disease has been described in isolated cases. The aim of this study is to systematically review the existing literature on AM-induced cardiomyopathy (AMIC). Methods The P...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203317734922

    authors: Tselios K,Deeb M,Gladman DD,Harvey P,Urowitz MB

    更新日期:2018-04-01 00:00:00

  • Severe tissue trauma triggers the autoimmune state systemic lupus erythematosus in the MRL/++ lupus-prone mouse.

    abstract::Tissue damage associated with a severe injury can result in profound inflammatory responses that may trigger autoimmune development in lupus-prone individuals. In this study, we investigated the role of a large full-thickness cutaneous burn injury on the early onset of autoimmune disease in lupus-prone MRL/++ mice. MR...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308097479

    authors: Anam K,Amare M,Naik S,Szabo KA,Davis TA

    更新日期:2009-04-01 00:00:00

  • Clinical profile of Chinese patients with systemic lupus erythematosus.

    abstract::In the 9-year period between 1982 and 1991, 137 patients attending a medical clinic of Queen Elizabeth Hospital, Hong Kong, were diagnosed as having systemic lupus erythematosus according to the American Rheumatism Association's criteria for classification. The female-to-male ratio was 16 to 1. Commonly the onset age ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339300200207

    authors: Lee SS,Li CS,Li PC

    更新日期:1993-04-01 00:00:00

  • Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study.

    abstract::Multiple sources were used to identify 325 systemic lupus erythematosus (SLE) patients within the city of Oslo during 1999-2009 who met ≥ 4 of the American College of Rheumatology (ACR) criteria. The survival, standard mortality rate (SMR), years of potential life loss before 60 years of age (YPLL60) and causes of dea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314551083

    authors: Lerang K,Gilboe IM,Steinar Thelle D,Gran JT

    更新日期:2014-12-01 00:00:00

  • Juvenile systemic lupus erythematosus in the Sultanate of Oman: clinical and immunological comparison between familial and non-familial cases.

    abstract::Consanguineous marriage is quite prevalent in the Sultanate of Oman, with up to 45% of marriages being consanguineous. The aim of this study was to determine demographic, clinical and serological characteristics between familial and non-familial cases of juvenile systemic lupus erythematosus (SLE) in a highly consangu...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203310383299

    authors: Abdwani R,Hira M,Al-Nabhani D,Al-Zakwani I

    更新日期:2011-03-01 00:00:00

  • Prevention of recurrent miscarriage in women with antiphospholipid syndrome: A systematic review and network meta-analysis.

    abstract:OBJECTIVES:To compare and rank currently available pharmacological interventions for the prevention of recurrent miscarriage (RM) in women with antiphospholipid syndrome (APS). METHODS:A search was performed using PubMed, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, CNKI, ClinicalTrials....

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203320967097

    authors: Yang Z,Shen X,Zhou C,Wang M,Liu Y,Zhou L

    更新日期:2021-01-01 00:00:00

  • Efficacy and safety of creatine supplementation in childhood-onset systemic lupus erythematosus: a randomized, double-blind, placebo-controlled, crossover trial.

    abstract:INTRODUCTION:Creatine supplementation has emerged as a promising non-pharmacological therapeutic strategy to counteract muscle dysfunction and low lean mass in a variety of conditions, including in pediatric and rheumatic diseases. The objective of this study was to examine the efficacy and safety of creatine supplemen...

    journal_title:Lupus

    pub_type: 杂志文章,随机对照试验

    doi:10.1177/0961203314546017

    authors: Hayashi AP,Solis MY,Sapienza MT,Otaduy MC,de Sá Pinto AL,Silva CA,Sallum AM,Pereira RM,Gualano B

    更新日期:2014-12-01 00:00:00

  • Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients.

    abstract::The objective of the study was to analyse the prevalence and clinical significance of hypocomplementemia in a large series of patients diagnosed either with systemic lupus erythematosus (SLE) or with primary antiphospholipid syndrome (APS) and its association with the main clinical, hematological and immunological fea...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1080oa

    authors: Ramos-Casals M,Campoamor MT,Chamorro A,Salvador G,Segura S,Botero JC,Yagüe J,Cervera R,Ingelmo M,Font J

    更新日期:2004-01-01 00:00:00

  • Headaches in patients with systemic lupus erythematosus: a comparative study.

    abstract::The incidence and nature of headaches in 85 systemic lupus erythematosus (SLE) patients attending an outpatient clinic were studied and compared to those experienced by 61 nurses. The two groups were similar in age, sex and ethnicity. Test-retest assessment of reliability gave both groups 95% confidence limits of 0.09...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203304lu1050oa

    authors: Whitelaw DA,Hugo F,Spangenberg JJ,Rickman R

    更新日期:2004-01-01 00:00:00

  • Lack of association of the TP53 Arg72Pro SNP and the MDM2 SNP309 with systemic lupus erythematosus in Caucasian, African American, and Asian children and adults.

    abstract::The p53 tumour suppressor is the central regulator of apoptosis. Previously, the functional TP53 Arg72Pro polymorphism was found to be associated with systemic lupus erythematosus (SLE) in Koreans but not Spaniards. MDM2 is the major negative regulator of p53. An intronic polymorphism in MDM2, the SNP309, attenuates p...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203308094558

    authors: Onel KB,Huo D,Hastings D,Fryer-Biggs J,Crow MK,Onel K

    更新日期:2009-01-01 00:00:00

  • Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.

    abstract::The objective was to investigate the relation between serum levels of interferon-alpha (IFN-alpha), the activity of an endogenous IFN-alpha inducing factor (SLE-IIF), clinical and immunological disease activity as well as serum levels of antiretroviral antibodies in SLE. Serum levels of IFN-alpha were measured in seri...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/096120300674499064

    authors: Bengtsson AA,Sturfelt G,Truedsson L,Blomberg J,Alm G,Vallin H,Rönnblom L

    更新日期:2000-01-01 00:00:00

  • What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?

    abstract::Heart valve disease (HVD) is the most common cardiac manifestation in the antiphospholipid syndrome (APS). Valve lesions should be described according to the established definition. HVD is progressive despite anticoagulant/antiplatelet treatments. Around 4-6% of patients with HVD in APS will require valve replacement ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314534307

    authors: Amigo MC

    更新日期:2014-10-01 00:00:00

  • Uncommon cutaneous manifestations of lupus erythematosus.

    abstract::Cutaneous manifestations of lupus erythematosus (LE) are, usually, characteristic enough to permit an easy diagnosis. However, some patients may present less typical lesions, associated or not to the classic ones. Therefore, irrespectively of the variety of LE (acute, subacute and chronic), in absence of the typical b...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/096120339700600207

    authors: Mascaro JM,Herrero C,Hausmann G

    更新日期:1997-01-01 00:00:00

  • Circulating CXCR5+CD4+helper T cells in systemic lupus erythematosus patients share phenotypic properties with germinal center follicular helper T cells and promote antibody production.

    abstract:OBJECTIVE:Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the production of autoantibodies. Recently, a specific highly activated T helper cell subset, follicular helper T (Tfh) cell, has emerged as a key immunoregulator of germinal center (GC) formation and high-affinity antibody productio...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314567750

    authors: Zhang X,Lindwall E,Gauthier C,Lyman J,Spencer N,Alarakhia A,Fraser A,Ing S,Chen M,Webb-Detiege T,Zakem J,Davis W,Choi YS,Quinet R

    更新日期:2015-08-01 00:00:00

  • Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).

    abstract::We studied IgG and IgM anticardiolipin antibodies (aCL) by an ELISA method in 80 Mexican systemic lupus erythematosus (SLE) patients and 378 of their first degree relatives. Sixty five percent of SLE patients and 16% of their relatives were positive for aCL. We also determined allele and haplotype frequencies of Major...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/096120339700600108

    authors: Granados J,Vargas-Alarcón G,Drenkard C,Andrade F,Melín-Aldana H,Alcocer-Varela J,Alarcón-Segovia D

    更新日期:1997-01-01 00:00:00

  • Musculoskeletal involvement in systemic lupus erythematosus.

    abstract::Involvement of the musculoskeletal system is common if not universal in the clinical course of systemic lupus erythematosus (SLE). Joint involvement on the whole does not cause major erosive disease, however, recent developments in musculoskeletal imaging show clearly the presence of significant bony and soft tissue i...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1191/0961203303lu2021oa

    authors: Zoma A

    更新日期:2004-01-01 00:00:00

  • Smoking is highly associated with discoid lupus erythematosus and lupus erythematosus tumidus: analysis of 405 patients.

    abstract:BACKGROUND:Environmental factors appear to play a role in the pathogenesis of lupus erythematosus (LE). OBJECTIVE:To determine the association between cigarette smoking and various types of cutaneous LE. DESIGN:Retrospective descriptive study at a dermatology clinic of a tertiary referral hospital. METHODS:All patie...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203314559630

    authors: Böckle BC,Sepp NT

    更新日期:2015-06-01 00:00:00

  • Early-stage predictors for treatment responses in patients with active lupus nephritis.

    abstract:OBJECTIVE:We analyzed data of lupus nephritis (LN) patients to find parameters that can predict remission. METHODS:Sixty-four LN patients who were diagnosed with class III, IV, V or V + III/IV by renal biopsy and were followed up for more than six months in our center were enrolled retrospectively. Receiver operating ...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203319826703

    authors: Liu G,Wang H,Le J,Lan L,Xu Y,Yang Y,Chen J,Han F

    更新日期:2019-03-01 00:00:00

  • Analysis of JC virus DNA in NPSLE patients treated with different immunomodulatory agents.

    abstract:OBJECTIVE:The objective of this report is to assess the presence and viral load of JC polyomavirus (JCV) DNA in cerebrospinal fluid (CSF) and plasma from neuropsychiatric systemic lupus erythematosus (NPSLE) patients in comparison to controls and to investigate if different types of immunosuppressive treatments were co...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203312470977

    authors: Iacobaeus E,Hopia L,Khademi M,Lundén M,Hammarin AL,Svenungsson E,Andersson M

    更新日期:2013-03-01 00:00:00

  • Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis.

    abstract::Objective We aimed to evaluate the relationship between telomere length and systemic lupus erythematosus (SLE). Methods PUBMED and EMBASE databases were searched; meta-analyses were performed comparing telomere length in SLE patients and healthy controls, and on SLE patients in subgroups based on ethnicity, sample typ...

    journal_title:Lupus

    pub_type: 杂志文章,meta分析

    doi:10.1177/0961203316662721

    authors: Lee YH,Jung JH,Seo YH,Kim JH,Choi SJ,Ji JD,Song GG

    更新日期:2017-03-01 00:00:00

  • Superior mesenteric artery syndrome and intra-abdominal compartment syndrome in systemic lupus erythematosus.

    abstract::Gastrointestinal manifestations of systemic lupus erythematosus (SLE) are common, occurring in about 50% of cases. They are usually mild, in the form of mouth ulcers, nausea, heartburn and mild abdominal pain, but they can be severe in cases of gastrointestinal vasculitis. In this report we describe an unusual combina...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203313517150

    authors: Bedaiwi M,Alkubeyyer MA,Al Arfaj AS

    更新日期:2014-02-01 00:00:00

  • What do we know about self-reported fatigue in systemic lupus erythematosus?

    abstract::Fatigue is one of the most complex and ill understood symptoms of chronic illness often reported as the number one complaint by patients with systemic lupus erythematosus (SLE). This paper aims to provide a comprehensive review of the literature on fatigue in SLE. A pool of 55 relevant articles was retrieved via elect...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203312436863

    authors: Cleanthous S,Tyagi M,Isenberg DA,Newman SP

    更新日期:2012-04-01 00:00:00

  • Serum level of proximal renal tubular epithelial cell-binding immunoglobulin G in patients with lupus nephritis.

    abstract::In vitro data showed that immunoglobulin G (IgG) from lupus nephritis (LN) patients could bind to proximal renal tubular epithelial cells (PTEC), but the clinical relevance of such binding remained unclear. Binding of IgG and subclasses to PTEC was measured by cellular ELISA (expressed as OD index) in 189 serial serum...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203315598018

    authors: Yap DY,Yung S,Zhang Q,Tang C,Chan TM

    更新日期:2016-01-01 00:00:00

  • Cyclophosphamide in combination with glucocorticoids for severe neuropsychiatric systemic lupus erythematosus: a retrospective, observational two-centre study.

    abstract::Cyclophosphamide (CYC) is used in severe neuropsychiatric systemic lupus erythematosus (NPSLE), but long-term data regarding its efficacy and safety are lacking. We identified NPSLE cases who received CYC from two centres during the period 1999-2013 and had regular follow-up. General and neuropsychiatric outcome at la...

    journal_title:Lupus

    pub_type: 杂志文章,多中心研究

    doi:10.1177/0961203315622821

    authors: Fanouriakis A,Pamfil C,Sidiropoulos P,Damian L,Flestea A,Gusetu G,Rednic S,Bertsias G,Boumpas DT

    更新日期:2016-05-01 00:00:00

  • SLEDAI-2K for a 30-day window.

    abstract::The aim of our study was to determine whether the SLEDAI-2K calculated using a timeframe of 30 days prior to a visit for clinical and laboratory variables was equivalent to the prescribed 10-day period. One hundred forty nine consecutive lupus patients seen over 9 weeks at the University of Toronto Lupus Clinic enroll...

    journal_title:Lupus

    pub_type: 杂志文章

    doi:10.1177/0961203309346505

    authors: Touma Z,Urowitz MB,Gladman DD

    更新日期:2010-01-01 00:00:00

  • A double-blind, placebo-controlled, clinical trial of dehydroepiandrosterone in severe systemic lupus erythematosus.

    abstract:OBJECTIVE:To determine if dehydroepiandrosterone (DHEA) is beneficial in severe systemic lupus erythematosus (SLE). METHODS:A double-blinded, placebo-controlled, randomized clinical trial in 21 patients with severe and active SLE, manifestated primarily by nephritis, serositis or hematological abnormalities. In additi...

    journal_title:Lupus

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1191/096120399678847588

    authors: van Vollenhoven RF,Park JL,Genovese MC,West JP,McGuire JL

    更新日期:1999-01-01 00:00:00

  • Cerebral sinovenous thrombosis in neonatal antiphospholipid syndrome: a new entity?

    abstract::Neonatal antiphospholipid syndrome (neonatal APS) seems to be exceedingly rare, as the antiphospholipid antibodies (aPL) related thrombosis in the neonatal period. The pathogenesis of perinatal aPL related thrombosis may be explained both by the transplacental passage of the maternal antibodies and by the production o...

    journal_title:Lupus

    pub_type: 杂志文章,评审

    doi:10.1177/0961203314560207

    authors: De Carolis MP,Salvi S,Botta A,Cocca C,Garufi C,Lanzone A,De Carolis S

    更新日期:2015-03-01 00:00:00